The respected finance director of AstraZeneca, Jon Symonds, may decide to
leave the FTSE100 drug-maker after he was edged out by David Brennan in the race
to replace AstraZeneca’s CEO Sir Tom McKillop.
Symonds, who has steered the company through a difficult period when its
shares plummeted due to problems with its drug development pipeline, said he
would ‘work it through’ with Brennan before making a decision about his future
at the group.
‘The best man won – that’s who the board picked,’ Symonds told The
If Symonds does leave AstraZeneca, the 100 Group, an association of FTSE100,
will be forced to recruit a new head, as Symonds currently chairs the
Does Darwin's theory apply to taxation? Colin ponders...
The EC has been instructed to draft a European Union (EU) directive authorising an EU financial transaction tax, which would apply to ten of the EU’s 28 member states
Accountancy watchdog the FRC has dropped its investigation into the former chief financial officer of Tesco, nearly two years after the supermarket was engulfed in an accounting scandal
Colin imagines how Apple's logo might change in the wake of the EC's ruling over its Irish tax arrangements